Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Return on Equity (2016 - 2021)

Syndax Pharmaceuticals has reported Return on Equity over the past 6 years, most recently at 0.1% for Q3 2021.

  • Quarterly results put Return on Equity at 0.1% for Q3 2021, up 37.0% from a year ago — trailing twelve months through Sep 2021 was 0.1% (up 37.0% YoY), and the annual figure for FY2025 was 1.42%, down 67.0%.
  • Return on Equity for Q3 2021 was 0.1% at Syndax Pharmaceuticals, up from 0.18% in the prior quarter.
  • Over the last five years, Return on Equity for SNDX hit a ceiling of 0.1% in Q3 2021 and a floor of 1.52% in Q4 2019.
  • Median Return on Equity over the past 5 years was 0.6% (2017), compared with a mean of 0.77%.
  • Biggest five-year swings in Return on Equity: plummeted -97bps in 2017 and later soared 115bps in 2020.
  • Syndax Pharmaceuticals' Return on Equity stood at 0.6% in 2017, then tumbled by -115bps to 1.29% in 2018, then dropped by -18bps to 1.52% in 2019, then soared by 76bps to 0.37% in 2020, then skyrocketed by 74bps to 0.1% in 2021.
  • The last three reported values for Return on Equity were 0.1% (Q3 2021), 0.18% (Q2 2021), and 0.23% (Q1 2021) per Business Quant data.